Manufacturing Improvements Sample Clauses
POPULAR SAMPLE Copied 2 times
Manufacturing Improvements. (a) For so long as Licensor, directly or through its Affiliates, is the exclusive supplier of the Clopidogrel Bulk pursuant to Section 3.1 hereof, BMS shall notify Licensor of any proposal to improve the manufacturing process used for the Clopidogrel Bulk and shall offer Licensor, by written notice, the right to participate in the development of such improvement by financing [*] of all development costs incurred after the receipt of such notice.
(b) If Licensor elects to participate in the development of such improvement within ninety (90) days after receipt of such notice and such development results in the issuance of a process patent, (i) the Parties and BMS shall amend and restate this Agreement so that BMS and Licensor shall share equally the economic benefit resulting from such patent and (ii) such patent shall be registered in the name of (x) BMS (who shall grant a license to Licensor with respect to such patent), if the patented process has applications other than in the manufacture of the Clopidogrel Bulk or (y) Licensor, if the patented process has applications only in the manufacture of the Clopidogrel Bulk.
(c) If Licensor does not elect to participate in such development within ninety (90) days after receipt of such notice and the proposed process has applications only in the manufacture of the Clopidogrel Bulk, then BMS shall not undertake any development work on such manufacturing process (whether directly, by licensing, or by transferring its know-how to, a Third Party) until termination of the Exclusive Supply Period.
Manufacturing Improvements. During the first [***] years of the term of this Agreement, the Parties will meet at least annually to review Manufacturing Improvements developed by either of the Parties outside of the course of the Collaboration. [***].
8.9.1 The entire right, title, and interest in and to all Manufacturing Improvements developed or invented solely by employees or consultants of Lilly during the term of this Agreement will be the sole and exclusive property of Lilly. [***].
8.9.2 The entire right, title, and interest in and to all Manufacturing Improvements developed or invented solely by employees or consultants of Isis during the term of this Agreement will be the sole and exclusive property of Isis. [***].
8.9.3 The entire right, title, and interest in and to all Manufacturing Improvements developed or invented jointly by employees or consultants of Isis and Lilly during the term of this Agreement will be the joint property of Isis and Lilly. Each Party will have an undivided joint ownership interest in such Manufacturing Improvements, and may license its rights under such Manufacturing Improvements for its own account and without the consent of the other Party, subject to the licenses granted to Lilly under Sections 8.1 and 8.2.
Manufacturing Improvements. The parties shall work together to reduce manufacturing costs and to improve yields, quality and performance. VisiJet shall have the right to request that the Products be sourced by ▇▇▇▇▇▇▇ through a third party, provided that such outsourcing reduces ▇▇▇▇▇▇▇'▇ cost and, the parties shall share any such cost savings equally by corresponding adjustments to the purchase price payable by VisiJet for such Products.
Manufacturing Improvements. Novogen Laboratories shall disclose to MEPL all Manufacturing Improvements immediately upon becoming aware of them, and by this document Novogen Laboratories assigns to MEPL absolutely and as beneficial owner its entire right, title to and interest in all Intellectual Property Rights in Manufacturing Improvements.
Manufacturing Improvements. Parent agrees that if, during the term of the Supply Agreement, the Roche Group implements any improvement in the manufacturing technology and know-how used in the manufacture of the Active Ingredient or the Product, it shall grant to Buyer a perpetual, paid-up, irrevocable, royalty-free, non-exclusive licence, with right to sub-licence, any such improvement for use in manufacture of the Active Ingredient or the Product for sale in the Territory. Buyer agrees that if, during the term of the Supply Agreement, Buyer or its assignee implements any improvement in the manufacturing technology and know-how used in the manufacture of the Active Ingredient or the Product, it shall grant to the Roche Group a perpetual, paid-up, irrevocable, royalty-free, non-exclusive licence, with right to sub-licence, any such improvement for use in manufacture of the Active Ingredient or the Product for sale outside the Territory.
Manufacturing Improvements. Subject to Section 2.14.1 (Process of Transition), the Parties shall consider whether to share manufacturing improvements with respect to Drug Product in circumstances where Amgen transitions manufacturing activities to Purchaser or a Third-Party manufacturer on behalf of Purchaser. Unless the Parties otherwise mutually agree in writing, neither Party shall have any obligation to share manufacturing improvements with respect to Transitioned Manufacturing with the other Party or its Third-Party manufacturer following the transition of such Transitioned Manufacturing.
Manufacturing Improvements. 4.7.1 The entire right, title, and interest in and to all Manufacturing Improvements developed or invented solely by employees, or consultants of OMI during the Term will be the sole and exclusive property of OMI. OMI hereby grants Isis a [***] license to practice under OMI’s rights to any Know-How or Patent claiming Manufacturing Improvements to [***] and to the extent that such Manufacturing Improvements are under the control of OMI. Notwithstanding the foregoing, Isis recognizes that OMI may not own or control Manufacturing Improvements developed or invented by a contract manufacturer. The license granted under this Section 4.7.1 falls within the restrictions [***].
4.7.2 The entire right, title, and interest in and to all Manufacturing Improvements developed or invented solely by employees, or consultants of Isis during the Term will be the sole and exclusive property of Isis. Isis hereby grants OMI [***] license to practice under Isis’ rights to any Know-How, Product Specific Know-How or Patent claiming such Manufacturing Improvements to make and have made Products. The license granted under this Section 4.7.2 will be sublicensable by OMI solely in connection with the grant of a license to develop, make, use, import, offer for sale and sell a Product.
4.7.3 The entire right, title, and interest in and to all Manufacturing Improvements developed or invented jointly by employees or consultants of Isis and OMI during the Term will be the joint property of Isis and OMI. Each Party will have an undivided joint ownership interest in such Manufacturing Improvements, and may license its rights under such Manufacturing Improvements for its own account and without the consent of the other Party, subject to the exclusivity granted to OMI under Section 2.3.
4.7.4 During the first [***], if requested by a Party, the Parties will meet annually to review Manufacturing Improvements developed by either of the Parties [***] of the Collaboration. At such time, the Parties will disclose all such Manufacturing Improvements Controlled by such Party in reasonable detail as to enable the other Party to [***] will have the right to [***] with respect to the commercialization of one or more [***]
Manufacturing Improvements. If ▇▇▇▇▇▇ generates any improvements or other inventions, information or know-how based on its work under this Agreement that relate to Bulk Drug Substance or Drug Product, including without limitation methods relating to the manufacture thereof (collectively, the "Manufacturing Improvements"), ▇▇▇▇▇▇ shall disclose all such Manufacturing Improvements to Altus. Altus shall own any such Manufacturing Improvements that relate to protein crystallization processes and techniques and/or formulations (the "Assigned Improvements"), and ▇▇▇▇▇▇ shall assign to Altus the entire right, title and interest in and to such Assigned Improvements. Altus shall ▇▇▇▇▇ ▇▇▇▇▇▇ the limited, non-exclusive, non-transferable right for ▇▇▇▇▇▇ to use any such Assigned Improvements in its manufacturing business, but provided that ▇▇▇▇▇▇ shall not have any license to use same to make a product that is competitive with any Altus product, product candidate, or technology or is otherwise a crystalline protein. ▇▇▇▇▇▇ shall own the entire right, title and interest in and to any other Manufacturing Improvements (that is, those that are not Assigned Improvements), and ▇▇▇▇▇▇ hereby grants and agrees to grant to Altus a non-exclusive, worldwide, royalty-free, fully paid, perpetual, irrevocable, worldwide license, including the right to sublicense, under any such other Manufacturing Improvements solely to make, have made, use, sell, have sold, offer for sale and import Bulk Drug Substance, Drug Product and products containing Bulk Drug Substance.
Manufacturing Improvements. The Parties agree that any Processing, Operations, Quality or Regulatory improvements in connection with Manufacturing of the Licensed Product for Development and Commercialization in the Field in the Licensed Territory, identified or developed by such Party, will be shared with the other Party prior to implementation through the JMC.
Manufacturing Improvements. Manufacturing Improvements" shall mean any inventions related to the Manufacture of Purchased Assets (including the KPT-350 molecule (also known as BIIB100) and the KPT 420 molecule) or of any other Manufacturing Intermediate made by Seller or Purchaser after the date of the Agreement that are created or developed in connection with the manufacturing activities for the Purchased Assets. Any Manufacturing Improvements solely related to Purchased Assets ("Purchaser's Manufacturing Improvements") shall be assigned to Purchaser. Ownership of all other Manufacturing Improvements ("Other Manufacturing Improvements") shall be determined in accordance with U.S. inventorship laws. In addition, Seller hereby grants to Purchaser a non-exclusive, irrevocable, worldwide license to its ownership interest in any Other Manufacturing Improvements related to the Purchased Assets solely for the Manufacture of any Purchased Asset. Purchaser, in turn, hereby grants to Seller a non-exclusive, irrevocable, worldwide license to its ownership interest in any Other Manufacturing Improvements solely for the Manufacture of any compounds that contain a shared intermediate or a similar synthetic step with any Purchased Asset.